- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02329353
Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers
January 9, 2017 updated by: Next Gen Pharma India Pvt. Ltd.
Clinical And Microbiological Analysis Of Orally Administered Lactobacillus Probiotic Lozenges In Chronic Periodontitis Patients Among Smokers And Non-smokers And Its Correlation With Clinical Parameters - A Clinico-Microbiological Study
Periodontitis is one of the most common chronic inflammatory disease with the etiology of bacterial plaque and is associated with a number of putative bacterial species.
The periodontal destruction is substantially mediated by the host, driven by the bacterial challenge.
The presence of pathogenic bacteria with the absence of so-called "beneficial bacteria" and the susceptibility of the host are the main aetiological factors of periodontal diseases.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Karnataka
-
Bangalore, Karnataka, India, 562157
- Krishnadevaraya college of dental sciences and hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
26 years to 51 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients free from any systemic illness
- Previously untreated moderate to severe generalised chronic periodontitis.
- Patients free from adverse reactions to lactose or fermented milk products
- Patient unwilling to quit smoking and smokers over the past one year ( Smoker arm).
Exclusion Criteria:
- Previous history of antibiotic usage over past 6 months
- Patients who are eligible for antibiotic usage during the treatment course
- Patients who are pregnant, lactating, alcoholic or who had undergone any surgical or nonsurgical therapy within 6 months.
- Acute oral lesions or necrotising ulcerative periodontitis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Smoker group
30 chronic periodontitis patients, having habit of smoking, with probing pocket depth of equal or greater than 5 mm with bleeding on probing and radio-graphic evidence of bone loss in at at least 2 sites at each quadrant will be given three probiotic lozenge per day for 8 weeks
|
Each lozenge contains not less than 1 billion Colony forming unit of Lactobacillus brevis CD2
Other Names:
|
|
Experimental: Non-smoker
30 chronic periodontitis patients, not having habit of smoking, with probing pocket depth of equal or greater than 5 mm with bleeding on probing and radio-graphic evidence of bone loss in at at least 2 sites at each quadrant will be given three probiotic lozenge per day for 8 weeks
|
Each lozenge contains not less than 1 billion Colony forming unit of Lactobacillus brevis CD2
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement in Clinical Periodontal Indices
Time Frame: 8 weeks
|
Improvement in clinical periodontal indices, namely, Plaque Index (PI), Gingival Index (GI), Probing Pocket Depth (PPD)
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in microbiological indices
Time Frame: 8 weeks
|
Porphyromonas gingivalis, Tanerella forsythus
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Rudrakshi chickanna, MDS, KRISHNADEVARAYA COLLEGE OF DENTAL SCIENCES AND HOSPITAL, BANGALORE
- Principal Investigator: Shruthi J R, BDS, KRISHNADEVARAYA COLLEGE OF DENTAL SCIENCES AND HOSPITAL, BANGALORE
- Principal Investigator: Prabhuji MLV, MDS, KRISHNADEVARAYA COLLEGE OF DENTAL SCIENCES AND HOSPITAL, BANGALORE
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2015
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
December 29, 2014
First Submitted That Met QC Criteria
December 29, 2014
First Posted (Estimate)
December 31, 2014
Study Record Updates
Last Update Posted (Estimate)
January 10, 2017
Last Update Submitted That Met QC Criteria
January 9, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BAN_PERIO-SOM_01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Periodontitis
-
Mahsa UniversityRecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage IIIMalaysia
-
Columbia UniversityCompletedPeriodontal Diseases | Generalized Moderate Chronic Periodontitis | Generalized Severe Chronic PeriodontitisUnited States
-
Gulf Medical UniversityCompletedPeriodontitis | Chronic Periodontitis (Disorder)United Arab Emirates
-
Loma Linda UniversityTerminated
-
Jorge GamonalUnknown-Chronic PeriodontitisChile
-
University Hospital HeidelbergRecruitingPeriodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Stage IVGermany
-
Government College of Dentistry, IndoreUnknown
-
Institute of Biophysics and Cell Engineering of...Belarusian Medical Academy of Post-Graduate EducationCompletedPeriodontitis, ChronicBelarus
-
Institute of Dental Sciences, Bareilly, Uttar Pradesh...UnknownCHRONIC PERIODONTITIS
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedChronic Periodontitis ComplexBrazil
Clinical Trials on Lactobacillus brevis CD2 Lozenges
-
Catholic University of the Sacred HeartUnknown
-
Next Gen Pharma India Pvt. Ltd.KVG Medical College and HospitalCompletedChronic PeriodontitisIndia
-
Next Gen Pharma India Pvt. Ltd.Peoples University, Bhanpur, BhopalCompleted
-
CD Pharma India Pvt. Ltd.Mahatma Gandhi Post-Graduate Institute of Dental SciencesCompletedChronic PeriodontitisIndia
-
All India Institute of Medical Sciences, New DelhiCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)WithdrawnPain | Head and Neck Cancer | Oral Complications of Radiation Therapy | Weight Changes
-
S. Andrea HospitalUnknown
-
Sahlgrenska University Hospital, SwedenBioGaia ABCompleted
-
University of L'AquilaCompletedChronic PeriodontitisItaly
-
University of Erlangen-NürnbergBioGaia ABRecruitingGingivitis | Orthodontic Appliance Complication | Periodontal InflammationGermany